OPKO Health Current Ratio 2010-2025 | OPK
OPKO Health current ratio from 2010 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| OPKO Health Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2025-03-31 | $0.74B | $0.30B | 2.49 |
| 2024-12-31 | $0.66B | $0.19B | 3.43 |
| 2024-09-30 | $0.63B | $0.21B | 2.98 |
| 2024-06-30 | $0.36B | $0.22B | 1.63 |
| 2024-03-31 | $0.39B | $0.20B | 1.92 |
| 2023-12-31 | $0.31B | $0.20B | 1.55 |
| 2023-09-30 | $0.36B | $0.20B | 1.78 |
| 2023-06-30 | $0.43B | $0.23B | 1.92 |
| 2023-03-31 | $0.41B | $0.22B | 1.83 |
| 2022-12-31 | $0.40B | $0.21B | 1.85 |
| 2022-09-30 | $0.41B | $0.27B | 1.55 |
| 2022-06-30 | $0.50B | $0.22B | 2.30 |
| 2022-03-31 | $0.75B | $0.31B | 2.44 |
| 2021-12-31 | $0.82B | $0.33B | 2.49 |
| 2021-09-30 | $0.56B | $0.28B | 1.97 |
| 2021-06-30 | $0.55B | $0.30B | 1.80 |
| 2021-03-31 | $0.60B | $0.40B | 1.48 |
| 2020-12-31 | $0.52B | $0.38B | 1.39 |
| 2020-09-30 | $0.43B | $0.34B | 1.28 |
| 2020-06-30 | $0.36B | $0.28B | 1.29 |
| 2020-03-31 | $0.27B | $0.25B | 1.12 |
| 2019-12-31 | $0.32B | $0.25B | 1.30 |
| 2019-09-30 | $0.29B | $0.27B | 1.08 |
| 2019-06-30 | $0.34B | $0.28B | 1.22 |
| 2019-03-31 | $0.44B | $0.40B | 1.10 |
| 2018-12-31 | $0.32B | $0.29B | 1.10 |
| 2018-09-30 | $0.29B | $0.32B | 0.91 |
| 2018-06-30 | $0.32B | $0.31B | 1.05 |
| 2018-03-31 | $0.35B | $0.32B | 1.10 |
| 2017-12-31 | $0.35B | $0.31B | 1.12 |
| 2017-09-30 | $0.43B | $0.26B | 1.66 |
| 2017-06-30 | $0.47B | $0.28B | 1.67 |
| 2017-03-31 | $0.46B | $0.27B | 1.74 |
| 2016-12-31 | $0.48B | $0.26B | 1.84 |
| 2016-09-30 | $0.50B | $0.26B | 1.97 |
| 2016-06-30 | $0.51B | $0.28B | 1.80 |
| 2016-03-31 | $0.45B | $0.27B | 1.70 |
| 2015-12-31 | $0.45B | $0.25B | 1.80 |
| 2015-09-30 | $0.52B | $0.36B | 1.45 |
| 2015-06-30 | $0.28B | $0.18B | 1.54 |
| 2015-03-31 | $0.39B | $0.18B | 2.16 |
| 2014-12-31 | $0.14B | $0.08B | 1.72 |
| 2014-09-30 | $0.16B | $0.08B | 2.12 |
| 2014-06-30 | $0.18B | $0.08B | 2.31 |
| 2014-03-31 | $0.21B | $0.09B | 2.43 |
| 2013-12-31 | $0.24B | $0.09B | 2.64 |
| 2013-09-30 | $0.24B | $0.07B | 3.38 |
| 2013-06-30 | $0.23B | $0.06B | 3.87 |
| 2013-03-31 | $0.24B | $0.06B | 4.08 |
| 2012-12-31 | $0.08B | $0.05B | 1.50 |
| 2012-09-30 | $0.09B | $0.05B | 1.90 |
| 2012-06-30 | $0.09B | $0.03B | 2.91 |
| 2012-03-31 | $0.10B | $0.03B | 3.35 |
| 2011-12-31 | $0.10B | $0.02B | 5.30 |
| 2011-09-30 | $0.12B | $0.02B | 5.81 |
| 2011-06-30 | $0.13B | $0.02B | 5.93 |
| 2011-03-31 | $0.14B | $0.03B | 5.79 |
| 2010-12-31 | $0.06B | $0.03B | 2.08 |
| 2010-09-30 | $0.05B | $0.02B | 2.21 |
| 2010-06-30 | $0.05B | $0.02B | 2.70 |
| 2010-03-31 | $0.06B | $0.03B | 2.10 |
| 2009-12-31 | $0.06B | $0.01B | 4.90 |
| 2009-09-30 | $0.07B | $0.00B | 16.52 |
| 2009-06-30 | $0.05B | $0.01B | 7.92 |
| 2009-03-31 | $0.01B | $0.01B | 0.88 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $1.079B | $0.713B |
| OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $183.740B | 80.48 |
| Thermo Fisher Scientific (TMO) | United States | $157.155B | 19.01 |
| Edwards Lifesciences (EW) | United States | $44.664B | 29.28 |
| Alcon (ALC) | Switzerland | $42.873B | 28.97 |
| IDEXX Laboratories (IDXX) | United States | $41.865B | 48.11 |
| DexCom (DXCM) | United States | $32.988B | 50.99 |
| IQVIA Holdings (IQV) | United States | $27.445B | 15.37 |
| Mettler-Toledo (MTD) | United States | $24.611B | 29.27 |
| STERIS (STE) | Ireland | $22.391B | 24.66 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.259B | 0.00 |
| Waters (WAT) | United States | $17.231B | 24.31 |
| Hologic (HOLX) | United States | $14.231B | 15.46 |
| Sysmex ADR (SSMXY) | Japan | $10.500B | 29.79 |
| Penumbra (PEN) | United States | $9.078B | 71.25 |
| Masimo (MASI) | United States | $8.645B | 31.89 |
| Globus Medical (GMED) | United States | $7.664B | 18.26 |
| Glaukos (GKOS) | United States | $5.628B | 0.00 |
| Teleflex (TFX) | United States | $5.008B | 8.27 |
| Integer Holdings (ITGR) | United States | $4.087B | 21.41 |
| TransMedics (TMDX) | United States | $3.833B | 83.32 |
| PROCEPT BioRobotics (PRCT) | United States | $3.156B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.344B | 13.96 |
| Nihon Kohden (NHNKY) | Japan | $2.188B | 25.10 |
| Veracyte (VCYT) | United States | $1.971B | 27.66 |
| Elekta AB (EKTAY) | Sweden | $1.876B | 16.86 |
| Alphatec Holdings (ATEC) | United States | $1.554B | 0.00 |
| Artivion (AORT) | United States | $1.345B | 125.96 |
| Pulse Biosciences (PLSE) | United States | $1.058B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.049B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.940B | 5.00 |
| IRadimed (IRMD) | United States | $0.736B | 37.36 |
| SiBone (SIBN) | United States | $0.729B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.585B | 12.67 |
| Beta Bionics (BBNX) | United States | $0.549B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.548B | 0.00 |
| AxoGen (AXGN) | United States | $0.538B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.530B | 8.24 |
| Pacific Biosciences Of California (PACB) | United States | $0.447B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.435B | 10.11 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.419B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.392B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.368B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.349B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.317B | 0.00 |
| NeuroPace (NPCE) | United States | $0.299B | 0.00 |
| RxSight (RXST) | United States | $0.296B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.260B | 0.00 |
| 908 Devices (MASS) | United States | $0.239B | 0.00 |
| Neuronetics (STIM) | United States | $0.238B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.228B | 13.79 |
| CVRx (CVRX) | United States | $0.220B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.211B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.181B | 0.00 |
| Inogen (INGN) | United States | $0.176B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.170B | 0.00 |
| LENSAR (LNSR) | United States | $0.155B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.144B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.144B | 0.00 |
| Accuray (ARAY) | United States | $0.139B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.118B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.115B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.107B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.093B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.075B | 0.00 |
| InspireMD (NSPR) | United States | $0.072B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.071B | 43.30 |
| Spectral AI (MDAI) | United States | $0.069B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.068B | 0.00 |
| Hyperfine (HYPR) | United States | $0.062B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.055B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.055B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.052B | 21.22 |
| Precision Optics (POCI) | United States | $0.037B | 0.00 |
| Envoy Medical (COCH) | United States | $0.035B | 0.00 |
| DarioHealth (DRIO) | United States | $0.032B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.022B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.021B | 0.00 | |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.007B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.56 |